Theravance Biopharma, Inc.
2021 Q4 - 2025 Q4 (16 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 1/26/2026 | 46 | 0.0% | 2,462 | 12/31/2025 |
| 2025 Q3 | 11/3/2025 | 28 | 0.0% | 1,947 | 9/30/2025 |
| 2025 Q2 | 7/21/2025 | 21 | 0.0% | 1,932 | 6/30/2025 |
| 2025 Q1 | 4/24/2025 | 15 | 0.0% | 1,645 | 3/31/2025 |
| 2024 Q4 | 1/27/2025 | 16 | 0.0% | 1,639 | 12/31/2024 |
| 2024 Q3 | 10/23/2024 | 14 | 0.0% | 1,769 | 9/30/2024 |
| 2024 Q2 | 7/30/2024 | 12 | 0.0% | 1,452 | 6/30/2024 |
| 2024 Q1 | 5/1/2024 | 557 | 0.0% | 52,876 | 3/31/2024 |
| 2023 Q4 | 1/24/2024 | 510 | 0.0% | 45,367 | 12/31/2023 |
| 2023 Q3 | 10/26/2023 | 384 | 0.0% | 44,532 | 9/30/2023 |
| 2023 Q2 | 8/10/2023 | 440 | 0.0% | 42,539 | 6/30/2023 |
| 2023 Q1 | 5/4/2023 | 576 | 0.0% | 53,060 | 3/31/2023 |
| 2022 Q4 | 2/9/2023 | 517 | 0.0% | 46,111 | 12/31/2022 |
| 2022 Q3 | 11/10/2022 | 419 | 0.0% | 41,351 | 9/30/2022 |
| 2022 Q2 | 8/15/2022 | 315 | 0.0% | 34,794 | 6/30/2022 |
| 2021 Q4 | 2/8/2022 | 110 | 0.0% | 10,022 | 12/31/2021 |